Abstract
Osteosarcoma is a rare disease in children but is one of the most common cancers in adult large breed dogs. The mutational landscape of both the primary and pulmonary metastatic tumor in two dogs with appendicular osteosarcoma (OSA) was comprehensively evaluated using an automated whole genome sequencing, exome and RNA-seq pipeline that was adapted for this study for use in dogs. Chromosomal lesions were the most common type of mutation. The mutational landscape varied substantially between dogs but the lesions within the same patient were similar. Copy number neutral loss of heterozygosity in mutant TP53 was the most significant driver mutation and involved a large region in the middle of chromosome 5. Canine and human OSA is characterized by loss of cell cycle checkpoint integrity and DNA damage response pathways. Mutational profiling of individual patients with canine OSA would be recommended prior to targeted therapy, given the heterogeneity seen in our study and previous studies.
Funder
American Kennel Club Canine Health Foundation
National Human Genome Research Institute
National Cancer Institute
Alvin J. Siteman Cancer Center
Foundation for Barnes-Jewish Hospital
Publisher
Public Library of Science (PLoS)
Reference104 articles.
1. Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand?;JK Anninga;Eur J Cancer,2011
2. Bone tumors in a population of 400 000 insured Swedish dogs up to 10 y of age: incidence and survival;A Egenvall;Can J Vet Res,2007
3. The epidemiology of osteosarcoma;G Ottaviani;Cancer Treat Res,2009
4. Risk Factors for Development of Canine and Human Osteosarcoma: A Comparative Review;KM Makielski;Vet Sci,2019
5. Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics;S Simpson;Acta Vet Scand,2017
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献